Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Waldenstrom Macroglobulinemia 1Recurrence 1Ovarian Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Promyelocytic, Acute 1Leukemia, Prolymphocytic 1Leukemia, Lymphocytic, Chronic, B-Cell 1Endometrial Neoplasms 1

Interventions

fludarabine phosphate 5Peripheral Blood Stem Cell Transplantation 4Whole-Body Irradiation 3Cyclophosphamide 3fludarabine 2Therapeutics 2Tacrolimus 2Mycophenolic Acid 2Methotrexate 2Filgrastim 2Cyclosporine 2Busulfan 2Antilymphocyte Serum 2Pentetic Acid 1Oxycodone 1Ondansetron 1Music Therapy 1Moxifloxacin 1Morphine 1Minocycline 1Methadone 1Massage 1Heparin 1Fluorescent Antibody Technique 1Ciprofloxacin 1Arsenic Trioxide 1Aprepitant 1Amoxicillin-Potassium Clavulanate Combination 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Leukemia, Prolymphocytic × Arsenic Trioxide × Clear all
NCT00005786 2013-02-01

Arsenic Trioxide in Treating Patients With Relapsed or Refractory Lymphoma or Leukemia

National Cancer Institute (NCI)

Phase NA Terminated
25 enrolled
LymphoidOther hematologic neoplasm

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic, Lymphoma, B-Cell, Marginal Zone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡